Fewer Observations, Shift In Emphasis Seen In FDA's Pandemic-Reduced Inspections

 
• By Bowman Cox
  
Inspector in plant
fda investigators observed some issues during the pandemic • Source: Alamy

More from Manufacturing

More from Compliance